Feedback
DIVISLAB 
Reputation: 642,713 • Aug 4, 2023 11:36 AM
Concord Biotech's niche API play holds promise for growth
ET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than 70 countries, including regulated markets like the United States, Europe and Japan.
The Economic Times
2 Votes
Comment
3 Shares
NSE:DIVISLAB price when posted: 3,726.3
View Votes